Found: 152
Select item for more details and to access through your institution.
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.
- Published in:
- Diabetologia, 2024, v. 67, n. 5, p. 822, doi. 10.1007/s00125-024-06099-3
- By:
- Publication type:
- Article
Long-term glucose variability and risk of nephropathy complication in UKPDS, ACCORD and VADT trials.
- Published in:
- Diabetologia, 2020, v. 63, n. 11, p. 2482, doi. 10.1007/s00125-020-05273-7
- By:
- Publication type:
- Article
An outcome model approach to transporting a randomized controlled trial results to a target population.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90).
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 10, p. 1, doi. 10.1111/dme.14656
- By:
- Publication type:
- Article
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 10, p. 1, doi. 10.1111/dme.14552
- By:
- Publication type:
- Article
Introduction.
- Published in:
- Diabetic Medicine, 2008, v. 25, p. 1, doi. 10.1111/j.1464-5491.2008.02539.x
- By:
- Publication type:
- Article
Sex differences in the complications, care and clinical outcomes of patients with type 2 diabetes in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1473, doi. 10.1111/dom.14993
- By:
- Publication type:
- Article
Impact of baseline kidney function on the effects of sodium‐glucose co‐transporter‐2 inhibitors on kidney and heart failure outcomes: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1341, doi. 10.1111/dom.14986
- By:
- Publication type:
- Article
Joint longitudinal and time‐to‐event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular disease: An analysis of the EXSCEL trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1261, doi. 10.1111/dom.14975
- By:
- Publication type:
- Article
Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR‐TIMI 53 cardiovascular outcomes trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 5, p. 1101, doi. 10.1111/dom.14313
- By:
- Publication type:
- Article
Effect of once‐weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2493, doi. 10.1111/dom.14175
- By:
- Publication type:
- Article
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA‐REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1151, doi. 10.1111/dom.14017
- By:
- Publication type:
- Article
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 798, doi. 10.1111/dom.13958
- By:
- Publication type:
- Article
Long‐term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2115, doi. 10.1111/dom.13788
- By:
- Publication type:
- Article
Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1576, doi. 10.1111/dom.13687
- By:
- Publication type:
- Article
Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2379, doi. 10.1111/dom.13377
- By:
- Publication type:
- Article
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1732, doi. 10.1111/dom.13292
- By:
- Publication type:
- Article
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1427, doi. 10.1111/dom.13242
- By:
- Publication type:
- Article
Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1587, doi. 10.1111/dom.12983
- By:
- Publication type:
- Article
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 791, doi. 10.1111/dom.12877
- By:
- Publication type:
- Article
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 356, doi. 10.1111/dom.12826
- By:
- Publication type:
- Article
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 78, doi. 10.1111/dom.12786
- By:
- Publication type:
- Article
Evaluation of the efficacy, safety and glycaemic effects of evolocumab ( AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 98, doi. 10.1111/dom.12788
- By:
- Publication type:
- Article
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy.
- Published in:
- Clinical Diabetes, 2009, v. 27, n. 1, p. 4, doi. 10.2337/diaclin.27.1.4
- By:
- Publication type:
- Article
Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 4, p. 885, doi. 10.1007/s13300-020-00782-5
- By:
- Publication type:
- Article
Timing of SGLT2i initiation after acute myocardial infarction.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-02000-5
- By:
- Publication type:
- Article
Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01802-x
- By:
- Publication type:
- Article
Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data.
- Published in:
- Medical Decision Making, 2020, v. 40, n. 4, p. 460, doi. 10.1177/0272989X20916442
- By:
- Publication type:
- Article
Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities.
- Published in:
- Medical Decision Making, 2010, v. 30, n. 3, p. 409, doi. 10.1177/0272989X09349960
- By:
- Publication type:
- Article
1418-P: Increased Risk of Incident Heart Failure and All-Cause Mortality in Insulin-Resistant People with Type 2 Diabetes in the United Kingdom Prospective Diabetes Study (UKPDS).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1418-P
- By:
- Publication type:
- Article
958-P: Once-Weekly Exenatide Effects on EGFR Slope and UACR as a Function of Baseline UACR: An EXSCEL Trial Post Hoc Analysis.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-958-P
- By:
- Publication type:
- Article
570-P: Osteoprotegerin Induces Endothelial Dysfunction and Is Associated with Vascular Complications In Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-570-P
- By:
- Publication type:
- Article
1479-P: Predictors of Incident Hospitalization for Heart Failure in the ACE Trial Population.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1479-P
- By:
- Publication type:
- Article
1466-P: Estimating Cardiovascular Risk in People with Type 2 Diabetes and Cardiovascular Disease: UKPDS Outcomes Model.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1466-P
- By:
- Publication type:
- Article
6-LB: Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-6-LB
- By:
- Publication type:
- Article
253-OR: Microvascular Complications in Latent Autoimmune Diabetes of Adults: Results from the UKPDS.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-253-OR
- By:
- Publication type:
- Article
2436-PUB: Predicting Risk for New-Onset Type 2 Diabetes in Chinese People with Coronary Heart Disease and Impaired Glucose Tolerance.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2436-PUB
- By:
- Publication type:
- Article
Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT.
- Published in:
- Diabetes, 2011, v. 60, n. 5, p. 1552, doi. 10.2337/db10-1392
- By:
- Publication type:
- Article
Life-Expectancy in Individuals with Type 2 Diabetes: Implications for Annuities.
- Published in:
- Diabetes, 2007, v. 56, p. A596
- By:
- Publication type:
- Article
Acarbose Cardiovascular Evaluation (ACE) Trial in Prediabetic Subjects with Cardiovascular Disease.
- Published in:
- Diabetes, 2007, v. 56, p. A596
- By:
- Publication type:
- Article
Rosiglitazone Decreases C-Reactive Protein (CRP) Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain.
- Published in:
- Diabetes, 2007, v. 56, p. A176
- By:
- Publication type:
- Article
The Oxford Risk Engine: A Cardiovascular Risk Calculator for Individuals with or without Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A170
- By:
- Publication type:
- Article
The Effectiveness of Metformin versus Glyburide in Type 2 Diabetes: Results from ADOPT (A Diabetes Outcomes Progression Trial).
- Published in:
- Diabetes, 2007, v. 56, p. A146
- By:
- Publication type:
- Article
Determinants of Monotherapy Failure in ADOPT (A Diabetes Outcomes Progression Trial).
- Published in:
- Diabetes, 2007, v. 56, p. A66
- By:
- Publication type:
- Article
Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes.
- Published in:
- Diabetes, 2006, v. 55, n. 8, p. 2357, doi. 10.2337/db06-0116
- By:
- Publication type:
- Article
Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.
- Published in:
- 2006
- By:
- Publication type:
- journal article
The Variable Number of Tandem Repeats Upstream of the Insulin Gene Is a Susceptibility Locus for Latent Autoimmune Diabetes in Adults.
- Published in:
- Diabetes, 2006, v. 55, n. 6, p. 1890, doi. 10.2337/db06-0089
- By:
- Publication type:
- Article
Risk Factors for Renal Dysfunction in Type 2 Diabetes.
- Published in:
- Diabetes, 2006, v. 55, n. 6, p. 1832, doi. 10.2337/db05-1620
- By:
- Publication type:
- Article
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01622-5
- By:
- Publication type:
- Article
Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01603-8
- By:
- Publication type:
- Article